Get your Emails warmed up and ready to send

Build sender reputation and reach more inboxes with automated email warmup.

Warm up your emails

Starting at $49/month

Start Warming Up

Georgia McGaughey

Board Member @Little Sparrows Technologies

Boston, MA, US
MOBILE NUMBERS
+12•••••••25

Signup · Get unlimited contacts

WORK HISTORY

Jun 2024 — Present

Board Member @Little Sparrows Technologies

Woburn, MA, US

Little Sparrows Technologies develops and manufactures medtech products. As an example, the bili-hut, is a high-intensity phototherapy device for treating jaundiced babies. As a Board member I provide strategic direction for the company at a global level for device(s) distribution. Topics include both capital and operational expenditures and clinical trials.

EDUCATION

2020 — 2021

Harvard Business School

Advanced Management Program (AMP199)

2023

Harvard Business School

Women on Boards

1991 — 1995

The University of Georgia

PhD, Physical Chemistry

SKILLS

Medicinal ChemistryBiochemistryDockingLifesciencesLife SciencesCheminformaticsComputational ChemistryBioinformaticsBiotechnologyMolecular ModelingInformaticsPharmaceutical IndustryDrug DevelopmentLead ChangeOrganic ChemistryProtein ChemistryDrug DesignMolecular BiologyChemistryDrug DiscoveryOrganic Synthesis

ABOUT GEORGIA MCGAUGHEY

SCIENTIFIC LEADER LEVERAGING DATA AND ADVANCED ANALYTICS with impact from research to FDA approval for small molecules and genetic therapies. Georgia has over 30 years of corporate experience in drug discovery and digital transformation obtained by working at Pfizer, Merck and Vertex. As a global leader, she is known for managing research data science teams which drive value for the business by discovering small molecules and cell and genetic therapies for unmet medical needs using transformative and innovative computational sciences approaches. She has led teams from basic research to FDA approval and has specialized experience in bringing medicines to market in rare diseases and leverages Artificial Intelligence (AI) to accelerate the drug discovery process where appropriate. She is known as a skilled mentor, global leader, and an exceptionally collaborative member of drug discovery programs.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.